Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome
- PMID: 29273311
- DOI: 10.1016/j.pec.2017.12.011
Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome
Abstract
Objective: The aim of the current study was to explore barriers to genetic counseling and testing in women with gynecological cancers deemed at significant risk of carrying a germline mutation.
Methods: A qualitative study using semi-structured interviews and inductively analysed thematically. Eight patients with ovarian or endometrial cancer participated in individual semi-structured telephone interviews that assessed motivation for genetic counseling and testing, perceived benefits and barriers, timing of the approach, perceptions of the referral process to genetic services and locus of control in relation to cancer and health.
Results: Analysis of the interview transcripts revealed five themes relating to perceptions of genetic counseling and testing: Lack of importance; Level of information received; Timing of referral processes; Fear and anxiety; Resistance to and perceptions of counseling.
Conclusions: Participants had a limited understanding of hereditary cancer syndromes and did not appreciate the benefits of genetic testing. A consistent approach at the time of referral to genetic services is needed to ensure that the level and format of information is appropriate for patients.
Practice implications: The rationale for genetic testing needs to be better explained to patients and the timing of referral should be based both on treatment priorities and patient preferences.
Keywords: BRCA1/2 testing; Barriers; Genetic counseling; Gynecologic cancers; Lynch syndrome testing.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.Breast Cancer Res Treat. 2013 Aug;141(1):135-44. doi: 10.1007/s10549-013-2669-9. Epub 2013 Aug 24. Breast Cancer Res Treat. 2013. PMID: 23974829
-
Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome.Obstet Gynecol Clin North Am. 2010 Mar;37(1):109-33, Table of Contents. doi: 10.1016/j.ogc.2010.03.003. Obstet Gynecol Clin North Am. 2010. PMID: 20494261 Review.
-
Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions.Gynecol Oncol. 2007 Nov;107(2):159-62. doi: 10.1016/j.ygyno.2007.09.031. Gynecol Oncol. 2007. PMID: 17950381
-
Population-based genetic testing for Women's cancer prevention.Best Pract Res Clin Obstet Gynaecol. 2020 May;65:139-153. doi: 10.1016/j.bpobgyn.2020.02.007. Epub 2020 Mar 2. Best Pract Res Clin Obstet Gynaecol. 2020. PMID: 32245629 Review.
-
Genetic testing by cancer site: ovary.Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2. Cancer J. 2012. PMID: 22846732 Review.
Cited by
-
Real-World Data on Institutional Implementation of Screening for Mismatch Repair Deficiency and Lynch Syndrome in Endometrial Cancer Patients.Cancers (Basel). 2024 Feb 4;16(3):671. doi: 10.3390/cancers16030671. Cancers (Basel). 2024. PMID: 38339422 Free PMC article.
-
Impact of changing guidelines on genetic testing and surveillance recommendations in a contemporary cohort of breast cancer survivors with family history of pancreatic cancer.Sci Rep. 2021 Jun 14;11(1):12491. doi: 10.1038/s41598-021-91971-0. Sci Rep. 2021. PMID: 34127761 Free PMC article.
-
Associations of sociodemographic and clinical factors with gastrointestinal cancer risk assessment appointment completion.J Genet Couns. 2020 Aug;29(4):616-624. doi: 10.1002/jgc4.1254. Epub 2020 Mar 30. J Genet Couns. 2020. PMID: 32227561 Free PMC article.
-
Factors impacting time to genetic diagnosis for children with epilepsy.Epilepsia Open. 2024 Dec;9(6):2495-2504. doi: 10.1002/epi4.13053. Epub 2024 Oct 28. Epilepsia Open. 2024. PMID: 39467089 Free PMC article.
-
Impact of barriers and motivators on intention and confidence to undergo hereditary cancer genetic testing.J Genet Couns. 2025 Feb;34(1):e1926. doi: 10.1002/jgc4.1926. Epub 2024 May 27. J Genet Couns. 2025. PMID: 38803214 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous